On 22 September, Sinovac wrote to the Minister of Health that they planned to begin verification of Phase 3 of the candidate vaccine, CoronaVac, in August, but the company spent the cash in the country because the Bangladeshi government had been slow to give the green light. to the demands.
Sinovac said he wasn’t sure he’d get bangladesh’s final approval. They called on the Coalition for Innovation in Epidemic Preparedness or CEPI to invest for the trial in Bangladesh, but never won it.
So they want the Bangladeshi government to invest cash for the protective test, the Beijing-based drug manufacturer added.
Sinovac would have to carry out the lawsuit with his own cash because that’s what they said they would do when they implemented for approval, health minister Zahid Maleque told bdnews24. com.
“(And) that’s why they were given permission, ” he said.
“They also said they would provide us with 100,000 doses of vaccine for free. We approved the essay after they wrote to us after discussions on all those issues. “
His branch checked, first icddr, by then directly, with Sinovac when the planned candidate vaccine test did not begin after regulatory approval, Maleque said.
«. . . They said they were in a currency crisis and asked us for funding.
“A country’s task is done when it approves the clinical trial of a vaccine. They never implemented for co-financing when they implemented for trial approval. This is not a contract we have with the Chinese government. It is a personal company and we have a co-financing (agreement) with a personal company. »
The Department of Health has still shared its position in writing.
It is entirely up to Sinovac, Maleque said when reporters recently asked him if the clinical trial of the vaccine in the country had stagnated: “We do not perceive why they act as they are. It’s a wonderful organization and it doesn’t run out of funds. “
Sinovac executive leader Yin Weidong said last month that countries that achieve their end-stage clinical trials, which come with Brazil, Indonesia, and Turkey, would get their coronavirus vaccines at the same time as China.
But the Minister of Health insisted that Bangladesh receive the Sinovac vaccine anyway, even if the test goes as planned.
“We can buy the vaccine if approved. Sinovac will work with WHO and deliver the vaccine to other countries. We’ll get it too,” Maleque added.
Bangladesh will also immediately benefit from the vaccine, which will work with India for its development.
Complications from the Fund have left the clinical trial of the candidate vaccine in limbo, Dr. Md Nazrul Islam, a member of the National Technical Advisory Committee on Coronavirus, told bdnews24. com. complications, he said.
“A first test may have been for us. Bangladesh had the opportunity. We have heard that Bangladesh will get more than 100,000 doses of vaccines at a very low rate and that some corporations in Bangladesh will be able to produce vaccines. “
“But none of this will be imaginable without a clinical trial here,” said Dr. Islam, former vice-chancellor of Bangabandhu Sheikh Mujib Medical University.
The International Center for Diarrhoeal Disease Research in Bangladesh intended to conduct the protective test and Sinovac began working with it from April.
On 18 July, the Bangladesh Medical Research Council or BMRC approved the clinical trial of the vaccine, while the Ministry of Health gave the green light on 27 August.
The vaccine is believed to be used in Units 1 and 2 of Dhaka Medical College Hospital, Mugda General Hospital, Dhaka Mohanagar General Hospital, Kurmitola General Hospital, Kuwait-Bangladesh Government Friendship Hospital and Holy Family Hospital. The final rehearsal is expected to last 18 months, on the country’s fitness workers.
After a clinical trial of 743 other people in the first and current phases, the Chinese company claimed to have discovered that the unproven vaccine worked because it created immunity opposed to the new coronavirus in those other people.